Anne Cross

6.9k total citations · 2 hit papers
42 papers, 4.1k citations indexed

About

Anne Cross is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Anne Cross has authored 42 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 17 papers in Infectious Diseases and 12 papers in Virology. Recurrent topics in Anne Cross's work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (12 papers) and Hepatitis B Virus Studies (11 papers). Anne Cross is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (12 papers) and Hepatitis B Virus Studies (11 papers). Anne Cross collaborates with scholars based in United States, Switzerland and Canada. Anne Cross's co-authors include Richard J. Colonno, Zachary Goodman, Richard B. Wilber, Ting‐Tsung Chang, Anna S. Lok, Deborah DeHertogh, Jose D. Sollano, Gerald Wolf, Hugo Cheinquer and Richard C. Zink and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Anne Cross

40 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

2006 1.1k citations Ting‐Tsung Chang, Robert G. Gish et al. New England Journal of Medicine profile →
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

2006 900 citations Ching‐Lung Lai, Daniel Shouval et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Cross United States	21	3.1k	2.5k	818	403	392	42	4.1k
Paul V. Holland United States	40	2.4k 0.8×	2.1k 0.9×	817 1.0×	193 0.5×	309 0.8×	140	5.4k
Jun Hayashi Japan	37	2.6k 0.8×	2.2k 0.9×	475 0.6×	130 0.3×	479 1.2×	215	4.5k
Seizaburo Kashiwagi Japan	33	2.1k 0.7×	1.1k 0.5×	411 0.5×	126 0.3×	279 0.7×	157	3.4k
Carla S. Coffin Canada	33	2.4k 0.8×	2.1k 0.9×	642 0.8×	76 0.2×	326 0.8×	139	3.4k
Massimo Resti Italy	32	2.3k 0.7×	1.6k 0.7×	312 0.4×	64 0.2×	234 0.6×	150	3.4k
James W. Mosley United States	33	2.7k 0.9×	2.5k 1.0×	919 1.1×	443 1.1×	98 0.3×	102	3.9k
Karine Lacombe France	34	2.5k 0.8×	2.1k 0.8×	1.3k 1.6×	243 0.6×	120 0.3×	219	3.7k
Michael Wulfsohn United States	18	2.5k 0.8×	2.0k 0.8×	1.4k 1.7×	670 1.7×	100 0.3×	35	4.5k
Caterina Sagnelli Italy	31	1.9k 0.6×	1.8k 0.7×	595 0.7×	60 0.1×	245 0.6×	170	3.2k
Annemarie Berger Germany	35	1.8k 0.6×	995 0.4×	1.7k 2.1×	736 1.8×	121 0.3×	130	3.7k

Countries citing papers authored by Anne Cross

Since Specialization

Citations

This map shows the geographic impact of Anne Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cross more than expected).

Fields of papers citing papers by Anne Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cross. The network helps show where Anne Cross may publish in the future.

Co-authorship network of co-authors of Anne Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Cross. A scholar is included among the top collaborators of Anne Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Cross. Anne Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bar‐Or, Amit, J. de Sèze, Jorge Correale, et al.. (2021). Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis (RMS) Patients from the Phase 3 ASCLEPIOS I and II Trials (1300). Neurology. 96(15_supplement). 9 indexed citations

Bar‐Or, Amit, Christopher Harp, Anne Cross, et al.. (2020). Factors associated with baseline serum neurofilament light concentrations in relapsing and primary progressive multiple sclerosis patients in the ocrelizumab OPERA 1 and ORATORIO Trials (2420). Neurology. 94(15_supplement). 1 indexed citations

Bar‐Or, Amit, Jeffrey A. Gelfand, Christopher Harp, et al.. (2018). Interim Analysis of the OBOE (Ocrelizumab Biomarker Outcome Evaluation) Study in Multiple Sclerosis (MS) (S24.002). Neurology. 90(15_supplement). 4 indexed citations

Leung, Nancy, Chung‐Kang Peng, Hie‐Won Hann, et al.. (2008). Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B. Hepatology. 49(1). 72–79. 146 indexed citations

Lai, Ching‐Lung, Daniel Shouval, Anna S. Lok, et al.. (2006). Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B. New England Journal of Medicine. 354(10). 1011–1020. 900 indexed citations breakdown →

Chang, Ting‐Tsung, Robert G. Gish, Robert de Man, et al.. (2006). A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B. New England Journal of Medicine. 354(10). 1001–1010. 1064 indexed citations breakdown →

Sherman, Morris, Cihan Yurdaydın, Jose D. Sollano, et al.. (2006). Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B. Gastroenterology. 130(7). 2039–2049. 308 indexed citations

Gathe, Joseph, et al.. (2002). Antiviral Activity of Enteric-Coated Didanosine, Stavudine, and Nelfinavir Versus Zidovudine Plus Lamivudine and Nelfinavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(4). 399–403. 14 indexed citations

Kelleher, Thomas, Anne Cross, & Lisa M. Dunkle. (1999). Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine. Clinical Therapeutics. 21(7). 1182–1192. 30 indexed citations

10.

Pollard, Richard B., Dolores M. Peterson, David J. Hardy, et al.. (1999). Safety and Antiretroviral Effects of Combined Didanosine and Stavudine Therapy in HIV-Infected Individuals With CD4 Counts of 200 to 500 cells/mm3. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 22(1). 39–39. 23 indexed citations

11.

Elion, Richard, Sanjeev Kaul, Catherine Knupp, et al.. (1999). The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection. Clinical Therapeutics. 21(11). 1853–1863. 3 indexed citations

12.

Petersen, E. A., C H Ramírez-Ronda, William D. Hardy, et al.. (1995). Dose-Related Activity Of Stavudine In Patients Infected With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 171(Supplement 2). S131–S139. 48 indexed citations

13.

Murray, Henry W., K. Squires, Wolfgang Weiß, et al.. (1995). Stavudine In Patients With Aids And Aids-Related Complex: Aids Clinical Trials Group 089. The Journal of Infectious Diseases. 171(Supplement 2). S123–S130. 42 indexed citations

14.

Anderson, Robert E., et al.. (1995). Design And Implementation Of The Stavudine Parallel-Track Program. The Journal of Infectious Diseases. 171(Supplement 2). S118–S122. 16 indexed citations

15.

Wolf, Gerald, Samuel E. Wilson, Anne Cross, Robert H. Deupree, & William B. Stason. (1993). Surgery or Balloon Angioplasty for Peripheral Vascular Disease: A Randomized Clinical Trial. Journal of Vascular and Interventional Radiology. 4(5). 639–648. 127 indexed citations

16.

Everett, Roger D., Anne Cross, & Anne Orr. (1993). A Truncated Form of Herpes Simplex Virus Type 1 Immediate-Early Protein Vmw110 Is Expressed in a Cell Type Dependent Manner. Virology. 197(2). 751–756. 93 indexed citations

17.

Kahn, James O., Stephen W. Lagakos, Douglas D. Richman, et al.. (1992). A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection. New England Journal of Medicine. 327(9). 581–587. 257 indexed citations

18.

Cross, Anne & Burton H. Singer. (1991). Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85(3). 349–355. 26 indexed citations

19.

Rozencweig, Marcel, C. McLaren, Mohan Beltangady, et al.. (1990). Overview of Phase I Trials of 2′,3′-Dideoxyinosine (ddI) Conducted on Adult Patients. Clinical Infectious Diseases. 12(Supplement_5). S570–S575. 49 indexed citations

20.

Wilson, Samuel E., Gerald Wolf, & Anne Cross. (1989). Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Journal of Vascular Surgery. 9(1). 1–9. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact